{"id":"https://openalex.org/W2092013291","doi":"https://doi.org/10.1111/j.1471-4159.1991.tb08247.x","title":"Prolonged Alterations in Canine Striatal Dopamine Metabolism Following Subtoxic Doses of l\u2010Methyl\u20104\u2010Phenyl\u2010 1,2,3,6\u2010Tetrahydropyridine (MPTP) and 4\u2032\u2010Amino\u2010MPTP Are Linked to the Persistence of Pyridinium Metabolites","display_name":"Prolonged Alterations in Canine Striatal Dopamine Metabolism Following Subtoxic Doses of l\u2010Methyl\u20104\u2010Phenyl\u2010 1,2,3,6\u2010Tetrahydropyridine (MPTP) and 4\u2032\u2010Amino\u2010MPTP Are Linked to the Persistence of Pyridinium Metabolites","publication_year":1991,"publication_date":"1991-09-01","ids":{"openalex":"https://openalex.org/W2092013291","doi":"https://doi.org/10.1111/j.1471-4159.1991.tb08247.x","mag":"2092013291","pmid":"https://pubmed.ncbi.nlm.nih.gov/1677682"},"language":"en","primary_location":{"id":"doi:10.1111/j.1471-4159.1991.tb08247.x","doi":"https://doi.org/10.1111/j.1471-4159.1991.tb08247.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.1991.tb08247.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024666338","display_name":"An N. Johannessen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285792802","display_name":"Center for Food Safety and Applied Nutrition","ror":"https://ror.org/05hzdft06","country_code":"US","type":"facility","lineage":["https://openalex.org/I1285792802","https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"An N. Johannessen","raw_affiliation_strings":["Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C., U.S.A","Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C., U.S.A","institution_ids":["https://openalex.org/I1285792802","https://openalex.org/I1320320070"]},{"raw_affiliation_string":"Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105935144","display_name":"Thomas J. Sobotka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285792802","display_name":"Center for Food Safety and Applied Nutrition","ror":"https://ror.org/05hzdft06","country_code":"US","type":"facility","lineage":["https://openalex.org/I1285792802","https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Sobotka","raw_affiliation_strings":["Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C., U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C., U.S.A","institution_ids":["https://openalex.org/I1285792802","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108403420","display_name":"Virginia K. Weise","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virginia K. Weise","raw_affiliation_strings":["Laboratory of Neural Regeneration, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neural Regeneration, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111562890","display_name":"Sanford P. Markey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanford P. Markey","raw_affiliation_strings":["Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5024666338"],"corresponding_institution_ids":["https://openalex.org/I1285792802","https://openalex.org/I1320320070","https://openalex.org/I4210158500"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":2.3024,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.87636956,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"57","issue":"3","first_page":"981","last_page":"990"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mptp","display_name":"MPTP","score":0.9089999794960022},{"id":"https://openalex.org/keywords/striatal-dopamine-metabolism","display_name":"striatal dopamine metabolism","score":0.8159999847412109},{"id":"https://openalex.org/keywords/dopamine-metabolites","display_name":"dopamine metabolites","score":0.6679999828338623},{"id":"https://openalex.org/keywords/dopac","display_name":"DOPAC","score":0.8510000109672546},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mpp","display_name":"MPP+","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tyrosine-hydroxylase","display_name":"tyrosine hydroxylase","score":0.9700000286102295},{"id":"https://openalex.org/keywords/nigral-dopaminergic-neurons","display_name":"nigral dopaminergic neurons","score":0.7580000162124634},{"id":"https://openalex.org/keywords/subtoxic-doses","display_name":"subtoxic doses","score":0.6140000224113464},{"id":"https://openalex.org/keywords/parkinson-s-disease-model","display_name":"Parkinson's disease model","score":0.6499999761581421},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5889999866485596},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.6200000047683716},{"id":"https://openalex.org/keywords/dopamine-depletion","display_name":"dopamine depletion","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.9892734289169312},{"id":"https://openalex.org/C2775841634","wikidata":"https://www.wikidata.org/wiki/Q903566","display_name":"Homovanillic acid","level":4,"score":0.8788720369338989},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6500983238220215},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6442581415176392},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.6083489060401917},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.531234085559845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5274702906608582},{"id":"https://openalex.org/C2775905480","wikidata":"https://www.wikidata.org/wiki/Q4634071","display_name":"3,4-Dihydroxyphenylacetic acid","level":5,"score":0.5163080096244812},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.4389049708843231},{"id":"https://openalex.org/C159167319","wikidata":"https://www.wikidata.org/wiki/Q420766","display_name":"Tyrosine hydroxylase","level":3,"score":0.41245898604393005},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3871333599090576},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22727617621421814},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.22120803594589233},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.1901683509349823},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17263692617416382},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.14837229251861572},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006719","descriptor_name":"Homovanillic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011726","descriptor_name":"Pyridinium Compounds","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014446","descriptor_name":"Tyrosine 3-Monooxygenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015102","descriptor_name":"3,4-Dihydroxyphenylacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015632","descriptor_name":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015632","descriptor_name":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1471-4159.1991.tb08247.x","doi":"https://doi.org/10.1111/j.1471-4159.1991.tb08247.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.1991.tb08247.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:1677682","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1677682","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1602098835","https://openalex.org/W1775749144","https://openalex.org/W1968645188","https://openalex.org/W1969800514","https://openalex.org/W1976245887","https://openalex.org/W1976801895","https://openalex.org/W1978117713","https://openalex.org/W1987655773","https://openalex.org/W1992333288","https://openalex.org/W2000778500","https://openalex.org/W2002186719","https://openalex.org/W2005507284","https://openalex.org/W2006371652","https://openalex.org/W2008660829","https://openalex.org/W2016095227","https://openalex.org/W2016923732","https://openalex.org/W2021044519","https://openalex.org/W2023837668","https://openalex.org/W2024498737","https://openalex.org/W2036911017","https://openalex.org/W2048917865","https://openalex.org/W2048950491","https://openalex.org/W2060354377","https://openalex.org/W2063099363","https://openalex.org/W2068900925","https://openalex.org/W2077260129","https://openalex.org/W2080341599","https://openalex.org/W2086208850","https://openalex.org/W2088002614","https://openalex.org/W2089420566","https://openalex.org/W2091038014","https://openalex.org/W2096623297","https://openalex.org/W2107878786","https://openalex.org/W2127850924","https://openalex.org/W2146889361","https://openalex.org/W2169622817","https://openalex.org/W2413548799"],"related_works":["https://openalex.org/W2050705027","https://openalex.org/W1966244573","https://openalex.org/W1968645188","https://openalex.org/W1975090288","https://openalex.org/W2006230427","https://openalex.org/W1981232750","https://openalex.org/W2430309802","https://openalex.org/W2027303088","https://openalex.org/W2086150553","https://openalex.org/W1974468297"],"abstract_inverted_index":{"Single":[0],"toxic":[1],"doses":[2,41,70,151],"of":[3,15,25,42,48,71,91,100,105,125,136,146,152,163,177,200,205,216,249,261],"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine":[4],"(MPTP).HCl":[5],"(2.5":[6],"mg/kg":[7,77,85],"i.v.)":[8,78,86],"and":[9,19,24,44,59,75,79,83,112,138,154,181,220,247,251],"4'-amino-MPTP.2HCl":[10],"(22.5":[11],"mg/kg)":[12],"induce":[13],"loss":[14,99,124,145],"striatal":[16,93,178,214,254],"dopamine":[17],"(DA)":[18],"tyrosine":[20],"hydroxylase":[21],"(TH)":[22],"activity":[23],"nigral":[26,101],"DA":[27,94,107,147,164,224,255],"neurons":[28],"in":[29,54,118,160,193,223,228,258],"the":[30,34,55,106,132,161,194,213,221,229,259,262],"dog.":[31],"To":[32],"examine":[33],"subacute":[35],"neurochemical":[36],"changes":[37],"induced":[38],"by":[39,234,253],"low":[40],"MPTP":[43,72,137,153,206],"4'-amino-MPTP,":[45],"dose-response":[46],"studies":[47],"these":[49,64,239,267],"compounds":[50],"were":[51,116],"carried":[52],"out":[53],"dog,":[56],"using":[57],"6-":[58],"3-week":[60],"survival":[61],"times":[62],"for":[63,172,196],"two":[65],"compounds,":[66],"respectively.":[67],"Low":[68],"single":[69,202],"(1.0,":[73],"0.5,":[74],"0.1":[76],"4'-amino-MPTP":[80,155],"(15,":[81],"7.5,":[82],"3.75":[84],"did":[87],"not":[88],"cause":[89],"depletion":[90],"canine":[92],"or":[95,97,167,207,218],"TH":[96],"a":[98,119,158,201,235],"neurons.":[102],"However,":[103],"levels":[104,183],"metabolites":[108,148],"3,4-dihydroxyphenylacetic":[109],"acid":[110,114],"(DOPAC)":[111],"homovanillic":[113],"(HVA)":[115],"decreased":[117],"dose-related":[120],"fashion,":[121],"with":[122],"significant":[123,236],"DOPAC":[126,166],"being":[127],"evident":[128],"6":[129],"weeks":[130,140,197],"after":[131,141],"lowest":[133],"administered":[134],"dose":[135,204],"3":[139],"4'-amino-MPTP.":[142,208],"This":[143],"selective":[144],"following":[149,198],"nontoxic":[150,203],"led":[156],"to":[157,165,189],"shift":[159],"ratio":[162,231],"HVA,":[168],"which":[169],"was":[170],"characteristic":[171],"each":[173],"compound.":[174],"The":[175],"measurement":[176],"1-methyl-4-phenylpyridinium":[179],"(MPP+)":[180],"4'-amino-MPP+":[182,219,252],"revealed":[184],"that":[185,244],"high":[186],"concentrations":[187],"(up":[188],"150":[190],"microM)":[191],"persist":[192],"striatum":[195],"administration":[199],"A":[209],"causal":[210],"relationship":[211],"between":[212,238],"concentration":[215],"MPP+":[217,250],"change":[222],"metabolism":[225],"as":[226],"reflected":[227],"DA/DOPAC":[230],"is":[232,242],"suggested":[233,243],"correlation":[237],"measures.":[240],"It":[241],"presynaptic":[245],"sequestration":[246],"retention":[248],"terminals":[256],"result":[257],"inhibition":[260],"monoamine":[263],"oxidase":[264],"contained":[265],"within":[266],"terminals.":[268]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}